Arlington, VA (PRWEB) October 27, 2022 AuntMinnie.com, a media property of Science and Medicine Group, has announced the winners of the 2022 edition of the
MINNEAPOLIS, June 10, 2021 (GLOBE NEWSWIRE) CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced the completion of the first clinical procedure with the company’s new lead implantation approach. The novel ultrasound-guided technique is the latest advancement of CVRx’s Barostim™ Baroreflex Activation Therapy (BAT™) to treat the symptoms of HF patients. The new approach further simplifies the implant procedure by using